Thromboxane B2-d9

• Description:

  Thromboxane B2-d9 is deuterium labeled Thromboxane B2. Thromboxane B2 is a prostaglandin derivative that is released during anaphylaxis. Thromboxane B2 induces arterial contraction and platelet aggregation[1].

• Product Name Alternative:

  PD-189659

• UNSPSC:

  12352211

• Target:

  Isotope-Labeled Compounds; Prostaglandin Receptor

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  GPCR/G Protein; Others

• Field of Research:

  Inflammation/Immunology

• Smiles:

  O[C@@H]1[C@@H] ([C@H] (OC (C1) O) /C=C/[C@H] (CC ([2H]) (C ([2H]) (C ([2H]) (C ([2H]) ([2H]) [2H]) [2H]) [2H]) [2H]) O) C/C=C\CCCC (O) =O

• Molecular Formula:

  C20H25D9O6

• Molecular Weight:

  379.54

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Isotope-Labeled Compounds

• Clinical Information:

  No Development Reported